Kahira Pharmaceuticals & Chemical Industries Company reported earnings results for the half year ended December 31, 2021. For the half year, the company reported sales was EGP 529.03 million compared to EGP 533.86 million a year ago. Net income was EGP 82.06 million compared to EGP 67 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
63.87 EGP | -.--% | -9.06% | +12.94% |
1st Jan change | Capi. | |
---|---|---|
+12.94% | 19.93M | |
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+18.53% | 330B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B |
- Stock Market
- Equities
- CPCI Stock
- News Kahira Pharmaceuticals & Chemical Industries Company
- Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Half Year Ended December 31, 2021